View Document Preview and Link Document Date: 2011-01-20 10:06:53 Open Document File Size: 816,79 KB Share Result on Facebook
City San Antonio / / Company IgG / Case / / Country United States / / Event Reorganization / / Facility Texas Health Science Center / Research Center University of Texas / Bone Building / Austin College of Pharmacy University / / IndustryTerm assessment tool / dual-energy x-ray absorptiometry / osteoporosis management / treatment of osteoporosis / state pharmaceutical / osteoporosis treatment / food restrictions / Osteoporosis Therapy / / MedicalCondition Diagnostic Criteria Classification Normal Osteopenia Osteoporosis Severe Osteoporosis / osteopenia / osteonecrosis / Cancer / Hypocalcemia / disease / available osteoporosis / long-term antiresorptive therapy Osteoporosis / erysipelas / dermatitis / cellulitis / eczema / secondary osteoporosis / vitamin D deficiency / Postmenopausal osteoporosis / Serious Adverse Events Cancer / pain / injury / fatal stroke / kyphosis / deformity / endocarditis / stomach upset / osteoporosis / Angina / oral osteoporosis / Infection / Senile osteoporosis Secondary - Typically / bone resorption / Adverse Events Infection / Back pain / pharyngitis / Anemia / hypercholesterolemia / skeletal disorder / / MedicalTreatment HRT / Hormone replacement therapy / / Organization U.S. Department of Health and Human Services / World Health Organization / University of Texas at Austin / Resident South Texas Veterans Health Care System San Antonio / Texas Pharmacotherapy Conference Pharmacotherapy Education and Research Center University / US Medicare / University of Texas Health Science Center at San Antonio / United States Food and Drug Administration / / Person Kristin L. Pareja / / Position Surgeon General / physician / / Product vitamin D / prednisone / adenosine / / ProvinceOrState Texas / Connecticut / / PublishedMedium Baseline / / RadioStation 5 WHO / / Region South Texas / / Technology x-ray / tomography / diagnostic tests / ultrasound / / URL www.shef.ac.uk/FRAX / www.nof.org / / SocialTag 
™ Denosumab (Prolia ) STRONG EVIDENCE IN THE CASE AGAINST OSTEOPOROSIS Kristin L. Pareja, Pharm.D.